With her recent groundbreaking findings in the field of RNA - mediated regulation based on the CRISPR - Cas9 system, E. Charpentier has laid the foundation for the development of a novel, highly versatile and specific genome editing technology that is
revolutionizing life sciences research and could open up whole new opportunities in biomedical gene therapies.